E7107
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for E7107, covering 2009-02-04 to 2009-03-24. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid Tumours [Phase 1]